{"id":5669,"date":"2015-02-24T09:00:00","date_gmt":"2015-02-24T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/"},"modified":"2024-09-23T11:22:41","modified_gmt":"2024-09-23T11:22:41","slug":"levermedicijn-vermindert-stressreactie-in-t1d","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/","title":{"rendered":"Levermedicijn vermindert stressreactie in T1D"},"content":{"rendered":"<a href=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2015\/02\/icoon-regeneratie1-2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-thumbnail wp-image-3241\" src=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg\" alt=\"icoon regeneratie[1]\" width=\"150\" height=\"150\" \/><\/a>Het levermedicijn TUDCA kan mogelijk de stressreactie in de b\u00e8tacellen bij Type 1 Diabetes verminderen. Het medicijn wordt nu gebruikt in de behandeling van gal- en leverziekten, maar kan dus ook een rol spelen bij T1D.\n<div class=\"text_exposed_show\">\n\nBreakthrough T1D is daarom gestart met een zogenoemde TUDCA trial. De eerste fase van deze trial is inmiddels afgerond en heeft aangetoond dat TUDCA in muizen T1D als het ware verminderd. Het helpt de b\u00e8tacellen om weerstand te bieden tegen de stress van de auto-immuun reactie. Hierdoor wordt de insulineproductie in het lichaam weer hoger.\n\nDe volgende fases van de trial zullen zich richten op het testen van TUDCA bij mensen. Ook kan worden onderzocht of TUDCA in combinatie met andere medicijnen T1D kan voorkomen.\n\nMeer weten?\n<a href=\"https:\/\/vimeo.com\/118597801\">Bekijk het filmpje<\/a> of <a href=\"http:\/\/jdrf.org\/2015\/02\/t1d-trial-looks-to-teach-an-old-drug-new-tricks\/\">lees hier<\/a>.\n\n<\/div>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Het levermedicijn TUDCA kan mogelijk de stressreactie in de b\u00e8tacellen bij Type 1 Diabetes verminderen. Het medicijn wordt nu gebruikt in de behandeling van gal- en leverziekten, maar kan dus ook een rol spelen bij T1D. Breakthrough T1D is daarom gestart met een zogenoemde TUDCA trial. De eerste fase van deze trial is inmiddels afgerond [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5669","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Levermedicijn vermindert stressreactie in T1D - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levermedicijn vermindert stressreactie in T1D - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Het levermedicijn TUDCA kan mogelijk de stressreactie in de b\u00e8tacellen bij Type 1 Diabetes verminderen. Het medicijn wordt nu gebruikt in de behandeling van gal- en leverziekten, maar kan dus ook een rol spelen bij T1D. Breakthrough T1D is daarom gestart met een zogenoemde TUDCA trial. De eerste fase van deze trial is inmiddels afgerond [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2015-02-24T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Levermedicijn vermindert stressreactie in T1D\",\"datePublished\":\"2015-02-24T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\"},\"wordCount\":140,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg\",\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\",\"name\":\"Levermedicijn vermindert stressreactie in T1D - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg\",\"datePublished\":\"2015-02-24T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levermedicijn vermindert stressreactie in T1D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levermedicijn vermindert stressreactie in T1D - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/","og_locale":"nl_NL","og_type":"article","og_title":"Levermedicijn vermindert stressreactie in T1D - Breakthrough T1D","og_description":"Het levermedicijn TUDCA kan mogelijk de stressreactie in de b\u00e8tacellen bij Type 1 Diabetes verminderen. Het medicijn wordt nu gebruikt in de behandeling van gal- en leverziekten, maar kan dus ook een rol spelen bij T1D. Breakthrough T1D is daarom gestart met een zogenoemde TUDCA trial. De eerste fase van deze trial is inmiddels afgerond [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/","og_site_name":"Breakthrough T1D","article_published_time":"2015-02-24T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:41+00:00","og_image":[{"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg","type":"","width":"","height":""}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Levermedicijn vermindert stressreactie in T1D","datePublished":"2015-02-24T09:00:00+00:00","dateModified":"2024-09-23T11:22:41+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/"},"wordCount":140,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg","articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/","name":"Levermedicijn vermindert stressreactie in T1D - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-150x150-2.jpg","datePublished":"2015-02-24T09:00:00+00:00","dateModified":"2024-09-23T11:22:41+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/levermedicijn-vermindert-stressreactie-in-t1d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Levermedicijn vermindert stressreactie in T1D"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5669"}],"version-history":[{"count":3,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5669\/revisions"}],"predecessor-version":[{"id":7992,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5669\/revisions\/7992"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}